Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Under Armour Inc Class A (UAA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Under Armour Inc Class A — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.55 (market cap $4.59B), while Under Armour Inc Class A trades at $4.88 (market cap $2.07B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2.2× Under Armour Inc Class A's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Under Armour Inc Class A for 99 Days on average.
| DFTX | UAA | |
|---|---|---|
Market Cap | $4.59B | $2.07B |
Volume | 2,103,937 | 12,050,442 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $8.14 |
52-Week Low | $10.68 | $4.17 |
Typical Hold Time | 0 Days | 99 Days |
Enterprise Value | $3.55B | $3.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Under Armour (UAA) trades at $4.82, down 1.23% amid ongoing revenue challenges despite recent earnings beats. The stock shows a bullish technical signal with mixed oscillators, while fundamentals reveal negative profitability metrics including -9.99% net income margin and -29.82% ROE. Recent news highlights the company's brand transformation efforts and international market resilience as it navigates softer North American demand.
The outlook remains cautious with analyst consensus at $5.79 target (20% upside) but 57% hold ratings. Key risks include persistent revenue declines, negative cash flow trends, and competitive pressures. Investment opportunity exists if margin improvements and international growth can offset domestic weakness, but execution risks remain elevated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Under Armour Inc Class A
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →
